Antibody data
- Antibody Data
- Antigen structure
- References [50]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10322-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10322-1-AP, RRID:AB_2251496
- Product name
- NUDT21 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated NUDT21 antibody (Cat. #10322-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Transposable element-gene chimera cartography, origination and role in enhancing transcriptome plasticity.
3'UTR shortening alleviates miRNA repression of mRNAs critical for muscle stem cell differentiation.
NUDT21-mediated Alternative Polyadenylation of CDK19 Reprograms Cholesterol Biosynthesis to Drive Colorectal Cancer Progression.
SNW1 promotes lymphatic metastasis in bladder cancer by modulating SRPK1 splicing.
Alternative Polyadenylation Contributes to Fibroblast Senescence in Pulmonary Fibrosis.
NUDT21 lactylation reprograms alternative polyadenylation to promote cuproptosis resistance.
RNA polymerase III transcription-associated polyadenylation promotes the accumulation of noncoding retrotransposons during infection.
Mediator regulates transcriptional termination through crosstalk with pre-mRNA 3' end processing factors.
IGF2BP2 binding to CPSF6 facilitates m6A-mediated alternative polyadenylation of PUM2 and promotes malignant progression in ovarian cancer.
Genetic Regulation of Alternative Polyadenylation Provides Novel Insights into Molecular Mechanisms Underlying Non-small Cell Lung Cancer.
Characterization and molecular targeting of CFIm25 (NUDT21/CPSF5) mRNA using miRNAs.
E3 ligase SYVN1-mediated polyubiquitination of CPSF6 promotes alternative polyadenylation and antivirus effects of macrophages.
CDC5L binds to ELAVL1 to inhibit pyroptosis in hepatocellular carcinoma through the Caspase 3/GSDME signaling pathway.
Alternative polyadenylation upon CPSF6 knock-out enhances HIV-1 infection in primary T cells.
RNA polymerase III transcription-associated polyadenylation promotes the accumulation of noncoding retrotransposons during infection.
IGF2BP3 recruits NUDT21 to regulate SPTBN1 alternative polyadenylation and drive ovarian cancer progression.
Unraveling the role of MiR-181 in skin fibrosis pathogenesis by targeting NUDT21.
TRIM65 deficiency alleviates renal fibrosis through NUDT21-mediated alternative polyadenylation.
RBBP6 maintains glioblastoma stem cells through CPSF3-dependent alternative polyadenylation.
Downregulation of CPSF6 leads to global mRNA 3' UTR shortening and enhanced antiviral immune responses.
Nudt21-mediated alternative polyadenylation of MZT1 3'UTR contributes to pancreatic cancer progression.
Alternative mRNA polyadenylation regulates macrophage hyperactivation via the autophagy pathway.
Disruption of CPSF6 enhances cellular permissivity to HIV-1 infection through alternative polyadenylation.
Dynamic regulation of alternative polyadenylation by PQBP1 during neurogenesis.
Mammalian cleavage factor 25 targets KLF14 to inhibit hepatic stellate cell activation and liver fibrosis.
CPSF6 regulates alternative polyadenylation and proliferation of cancer cells through phase separation.
Synergistic inhibition of NUDT21 by secretory S100A11 and exosomal miR-487a-5p promotes melanoma oligo- to poly-metastatic progression.
CFIm25 regulates human stem cell function independently of its role in mRNA alternative polyadenylation.
Distinct, opposing functions for CFIm59 and CFIm68 in mRNA alternative polyadenylation of Pten and in the PI3K/Akt signalling cascade.
NUDT21 Promotes Tumor Growth and Metastasis Through Modulating SGPP2 in Human Gastric Cancer.
Alternative polyadenylation is a determinant of oncogenic Ras function.
NUDT21 Suppresses Breast Cancer Tumorigenesis Through Regulating CPSF6 Expression.
ARS2 Regulates Nuclear Paraspeckle Formation through 3'-End Processing and Stability of NEAT1 Long Noncoding RNA.
Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation.
CFIm25-regulated lncRNA acv3UTR promotes gastric tumorigenesis via miR-590-5p/YAP1 axis.
Partial loss of CFIm25 causes learning deficits and aberrant neuronal alternative polyadenylation.
Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis.
A Complex of U1 snRNP with Cleavage and Polyadenylation Factors Controls Telescripting, Regulating mRNA Transcription in Human Cells.
Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation.
THZ1 suppresses human non-small-cell lung cancer cells in vitro through interference with cancer metabolism.
The mRNA Export Receptor NXF1 Coordinates Transcriptional Dynamics, Alternative Polyadenylation, and mRNA Export.
Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Effect of CFIm25 knockout on RNA polymerase II transcription.
CFIm25 regulates glutaminase alternative terminal exon definition to modulate miR-23 function.
Coupling between alternative polyadenylation and alternative splicing is limited to terminal introns.
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors.
The Mediator subunit MED23 couples H2B mono-ubiquitination to transcriptional control and cell fate determination.
CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.
Evidence that cleavage factor Im is a heterotetrameric protein complex controlling alternative polyadenylation.
Pre-messenger RNA cleavage factor I (CFIm): potential role in alternative polyadenylation during spermatogenesis.
Cheon Y, Alvstad EG, Torre D, Quach DT, Nguyen J, Hyun K, Zhou M, Yu T, Liu L, Yoon Y, Reese F, Faraone L, Li Y, Arnold FJ, Fstkchyan YS, Basu U, Kvon E, Valente EM, Ho JSY, Byun M, Guccione E, Shi Y, Weng Z, Seldin M, Marazzi I
Nature structural & molecular biology 2026 Mar;33(3):448-463
Nature structural & molecular biology 2026 Mar;33(3):448-463
3'UTR shortening alleviates miRNA repression of mRNAs critical for muscle stem cell differentiation.
Zhu Y, Wang J, Tong D, Jia P, Chen S, Li Y, Fu J, Li Q, Hu P, Zhou Y, Cheng H
The EMBO journal 2026 Feb;45(3):722-748
The EMBO journal 2026 Feb;45(3):722-748
NUDT21-mediated Alternative Polyadenylation of CDK19 Reprograms Cholesterol Biosynthesis to Drive Colorectal Cancer Progression.
Yu Y, Ma J, Zhou M, Gu X, Zhou Y, Li Z, Zhang T, Gong W, Huang C, Xiang J
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Feb;13(7):e18346
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Feb;13(7):e18346
SNW1 promotes lymphatic metastasis in bladder cancer by modulating SRPK1 splicing.
Hu J, Zhu Y, Wang G, Dai H, Han H, Cao W, Ding M, Diao W, Lu Q, Zhang Q, Guo H, Chen W
iScience 2026 Feb 20;29(2):114811
iScience 2026 Feb 20;29(2):114811
Alternative Polyadenylation Contributes to Fibroblast Senescence in Pulmonary Fibrosis.
Huang J, Gacha-Garay MJ, Wang Y, Collum SD, Girard RA, Puente H, Yoo SH, Hussain R, Patel J, Patel M, Wagner EJ, KrishnaYalamanchili H, Karmouty-Quintana H, Chen Z, Mills T
Aging cell 2025 Oct;24(10):e70179
Aging cell 2025 Oct;24(10):e70179
NUDT21 lactylation reprograms alternative polyadenylation to promote cuproptosis resistance.
Lin J, Yin Y, Cao J, Zhang Y, Chen J, Chen R, Zou B, Huang C, Lv Y, Xu S, Yang H, Lin P, Xie D
Cell discovery 2025 May 28;11(1):52
Cell discovery 2025 May 28;11(1):52
RNA polymerase III transcription-associated polyadenylation promotes the accumulation of noncoding retrotransposons during infection.
Lari A, Shah SB, Mao X, Sanghrajka P, Karijolich J, Lareau LF, Glaunsinger BA
bioRxiv : the preprint server for biology 2025 May 15;
bioRxiv : the preprint server for biology 2025 May 15;
Mediator regulates transcriptional termination through crosstalk with pre-mRNA 3' end processing factors.
Lu C, Bai X, Zhang H, Zhang Y, Yang M, Zheng Y, Jin Z, Yang W, Guo G, Huang Q, Huang Y, Wu L, Fu XD, Zhang Z, Wang G
Molecular cell 2025 Jun 5;85(11):2147-2164.e10
Molecular cell 2025 Jun 5;85(11):2147-2164.e10
IGF2BP2 binding to CPSF6 facilitates m6A-mediated alternative polyadenylation of PUM2 and promotes malignant progression in ovarian cancer.
Luo X, Wei Q, Xie L, Chen N, Gu B, Xu J, Jiang X, Zuo X, Zhao H, Liu X, Yang Y, Liu T, Zhu Y, Yi P, Xu J
Clinical and translational medicine 2025 Jul;15(7):e70388
Clinical and translational medicine 2025 Jul;15(7):e70388
Genetic Regulation of Alternative Polyadenylation Provides Novel Insights into Molecular Mechanisms Underlying Non-small Cell Lung Cancer.
Jin M, Huang Y, Li B, Wang Y, Li Y, Chen Z, Tang Z, Liu C, Zhang L, Yuan X, Tian J, Liu B
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Jul;12(26):e2502008
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Jul;12(26):e2502008
Characterization and molecular targeting of CFIm25 (NUDT21/CPSF5) mRNA using miRNAs.
Khan N, Gupta M, Masamha CP
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2025 Jan 31;39(2):e70324
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2025 Jan 31;39(2):e70324
E3 ligase SYVN1-mediated polyubiquitination of CPSF6 promotes alternative polyadenylation and antivirus effects of macrophages.
Lu X, Liu C, Wu R, Hu Z, Liu S, Li X, Liu Y, Li M, Liang J, Huang Y, Han Y, Ou X, Deng K, Liang C, Chen S, Fu Y, Xu A
Cell reports 2025 Feb 25;44(2):115276
Cell reports 2025 Feb 25;44(2):115276
CDC5L binds to ELAVL1 to inhibit pyroptosis in hepatocellular carcinoma through the Caspase 3/GSDME signaling pathway.
Liang S, Zhu Z, Tang Y, Zhou S, Xiao M, Gong X, Ye K
International journal of molecular medicine 2025 Dec;56(6)
International journal of molecular medicine 2025 Dec;56(6)
Alternative polyadenylation upon CPSF6 knock-out enhances HIV-1 infection in primary T cells.
Cornish D, Jackson-Jones KA, Ling-Hu T, Simons LM, Cisneros WJ, Kuffour EO, Stegman N, Agnes F, Lee Y, Sharma VP, Bieniasz PD, Lorenzo-Redondo R, Hultquist JF
PLoS pathogens 2025 Dec;21(12):e1013745
PLoS pathogens 2025 Dec;21(12):e1013745
RNA polymerase III transcription-associated polyadenylation promotes the accumulation of noncoding retrotransposons during infection.
Lari A, Shah SB, Mao X, Sanghrajka P, Karijolich J, Lareau LF, Glaunsinger BA
Proceedings of the National Academy of Sciences of the United States of America 2025 Aug 12;122(32):e2507186122
Proceedings of the National Academy of Sciences of the United States of America 2025 Aug 12;122(32):e2507186122
IGF2BP3 recruits NUDT21 to regulate SPTBN1 alternative polyadenylation and drive ovarian cancer progression.
Luo X, Xie L, Ma X, Chen N, Xu J, Jiang X, Liu X, Yang Y, Liu T, Yi P, Xu J
Communications biology 2025 Apr 29;8(1):680
Communications biology 2025 Apr 29;8(1):680
Unraveling the role of MiR-181 in skin fibrosis pathogenesis by targeting NUDT21.
Mills TW, Wu M, Alonso J, Puente H, Charles J, Chen Z, Yoo SH, Mayes MD, Assassi S
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2024 Sep;38(17):e70022
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2024 Sep;38(17):e70022
TRIM65 deficiency alleviates renal fibrosis through NUDT21-mediated alternative polyadenylation.
Wei S, Huang X, Zhu Q, Chen T, Zhang Y, Tian J, Pan T, Zhang L, Xie T, Zhang Q, Kuang X, Lei E, Li Y
Cell death and differentiation 2024 Nov;31(11):1422-1438
Cell death and differentiation 2024 Nov;31(11):1422-1438
RBBP6 maintains glioblastoma stem cells through CPSF3-dependent alternative polyadenylation.
Lin P, Chen W, Long Z, Yu J, Yang J, Xia Z, Wu Q, Min X, Tang J, Cui Y, Liu F, Wang C, Zheng J, Li W, Rich JN, Li L, Xie Q
Cell discovery 2024 Mar 19;10(1):32
Cell discovery 2024 Mar 19;10(1):32
Downregulation of CPSF6 leads to global mRNA 3' UTR shortening and enhanced antiviral immune responses.
Ge Y, Huang J, Chen R, Fu Y, Ling T, Ou X, Rong X, Cheng Y, Lin Y, Zhou F, Lu C, Yuan S, Xu A
PLoS pathogens 2024 Feb;20(2):e1012061
PLoS pathogens 2024 Feb;20(2):e1012061
Nudt21-mediated alternative polyadenylation of MZT1 3'UTR contributes to pancreatic cancer progression.
Zhou Y, Yang J, Huang L, Liu C, Yu M, Chen R, Zhou Q
iScience 2024 Feb 16;27(2):108822
iScience 2024 Feb 16;27(2):108822
Alternative mRNA polyadenylation regulates macrophage hyperactivation via the autophagy pathway.
Chen Y, Chen B, Li J, Li H, Wang G, Cai X, Zhang Q, Liu X, Kan C, Wang L, Wang Z, Li HB
Cellular & molecular immunology 2024 Dec;21(12):1522-1534
Cellular & molecular immunology 2024 Dec;21(12):1522-1534
Disruption of CPSF6 enhances cellular permissivity to HIV-1 infection through alternative polyadenylation.
Hultquist J, Cornish D, Jackson-Jones K, Ling-Hu T, Simons L, Cisneros W, Kuffour E, Agnes F, Lee Y, Bieniasz P, Lorenzo-Redondo R
Research square 2024 Dec 4;
Research square 2024 Dec 4;
Dynamic regulation of alternative polyadenylation by PQBP1 during neurogenesis.
Liu X, Xie H, Liu W, Zuo J, Li S, Tian Y, Zhao J, Bai M, Li J, Bao L, Han J, Zhang ZC
Cell reports 2024 Aug 27;43(8):114525
Cell reports 2024 Aug 27;43(8):114525
Mammalian cleavage factor 25 targets KLF14 to inhibit hepatic stellate cell activation and liver fibrosis.
Chen X, Shi W, Zhu L, Zhou X, Wang Y
Cellular signalling 2023 Sep;109:110752
Cellular signalling 2023 Sep;109:110752
CPSF6 regulates alternative polyadenylation and proliferation of cancer cells through phase separation.
Liu S, Wu R, Chen L, Deng K, Ou X, Lu X, Li M, Liu C, Chen S, Fu Y, Xu A
Cell reports 2023 Oct 31;42(10):113197
Cell reports 2023 Oct 31;42(10):113197
Synergistic inhibition of NUDT21 by secretory S100A11 and exosomal miR-487a-5p promotes melanoma oligo- to poly-metastatic progression.
Zeng B, Chen Y, Chen H, Zhao Q, Sun Z, Liu D, Li X, Zhang Y, Wang J, Xing HR
Molecular oncology 2023 Dec;17(12):2743-2766
Molecular oncology 2023 Dec;17(12):2743-2766
CFIm25 regulates human stem cell function independently of its role in mRNA alternative polyadenylation.
Ran Y, Huang S, Shi J, Feng Q, Deng Y, Xiang AP, Yao C
RNA biology 2022;19(1):686-702
RNA biology 2022;19(1):686-702
Distinct, opposing functions for CFIm59 and CFIm68 in mRNA alternative polyadenylation of Pten and in the PI3K/Akt signalling cascade.
Tseng HW, Mota-Sydor A, Leventis R, Jovanovic P, Topisirovic I, Duchaine TF
Nucleic acids research 2022 Sep 9;50(16):9397-9412
Nucleic acids research 2022 Sep 9;50(16):9397-9412
NUDT21 Promotes Tumor Growth and Metastasis Through Modulating SGPP2 in Human Gastric Cancer.
Zhu Y, Zhang R, Zhang Y, Cheng X, Li L, Wu Z, Ding K
Frontiers in oncology 2021;11:670353
Frontiers in oncology 2021;11:670353
Alternative polyadenylation is a determinant of oncogenic Ras function.
Subramanian A, Hall M, Hou H, Mufteev M, Yu B, Yuki KE, Nishimura H, Sathaseevan A, Lant B, Zhai B, Ellis J, Wilson MD, Daugaard M, Derry WB
Science advances 2021 Dec 17;7(51):eabh0562
Science advances 2021 Dec 17;7(51):eabh0562
NUDT21 Suppresses Breast Cancer Tumorigenesis Through Regulating CPSF6 Expression.
Wang BJ, Liu DC, Guo QY, Han XW, Bi XM, Wang H, Wu ZS, Wu WY
Cancer management and research 2020;12:3069-3078
Cancer management and research 2020;12:3069-3078
ARS2 Regulates Nuclear Paraspeckle Formation through 3'-End Processing and Stability of NEAT1 Long Noncoding RNA.
Machitani M, Taniguchi I, Ohno M
Molecular and cellular biology 2020 Jan 30;40(4)
Molecular and cellular biology 2020 Jan 30;40(4)
Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation.
Weng T, Huang J, Wagner EJ, Ko J, Wu M, Wareing NE, Xiang Y, Chen NY, Ji P, Molina JG, Volcik KA, Han L, Mayes MD, Blackburn MR, Assassi S
The Journal of experimental medicine 2020 Feb 3;217(2)
The Journal of experimental medicine 2020 Feb 3;217(2)
CFIm25-regulated lncRNA acv3UTR promotes gastric tumorigenesis via miR-590-5p/YAP1 axis.
Liu K, Wang BJ, Han W, Chi CH, Gu C, Wang Y, Fu X, Huang W, Liu Z, Song X
Oncogene 2020 Apr;39(15):3075-3088
Oncogene 2020 Apr;39(15):3075-3088
Partial loss of CFIm25 causes learning deficits and aberrant neuronal alternative polyadenylation.
Alcott CE, Yalamanchili HK, Ji P, van der Heijden ME, Saltzman A, Elrod N, Lin A, Leng M, Bhatt B, Hao S, Wang Q, Saliba A, Tang J, Malovannaya A, Wagner EJ, Liu Z, Zoghbi HY
eLife 2020 Apr 22;9
eLife 2020 Apr 22;9
Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis.
Ko J, Mills T, Huang J, Chen NY, Mertens TCJ, Collum SD, Lee G, Xiang Y, Han L, Zhou Y, Lee CG, Elias JA, Jyothula SSK, Rajagopal K, Karmouty-Quintana H, Blackburn MR
The Journal of biological chemistry 2019 Oct 25;294(43):15781-15794
The Journal of biological chemistry 2019 Oct 25;294(43):15781-15794
A Complex of U1 snRNP with Cleavage and Polyadenylation Factors Controls Telescripting, Regulating mRNA Transcription in Human Cells.
So BR, Di C, Cai Z, Venters CC, Guo J, Oh JM, Arai C, Dreyfuss G
Molecular cell 2019 Nov 21;76(4):590-599.e4
Molecular cell 2019 Nov 21;76(4):590-599.e4
Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation.
Weng T, Ko J, Masamha CP, Xia Z, Xiang Y, Chen NY, Molina JG, Collum S, Mertens TC, Luo F, Philip K, Davies J, Huang J, Wilson C, Thandavarayan RA, Bruckner BA, Jyothula SS, Volcik KA, Li L, Han L, Li W, Assassi S, Karmouty-Quintana H, Wagner EJ, Blackburn MR
The Journal of clinical investigation 2019 May 1;129(5):1984-1999
The Journal of clinical investigation 2019 May 1;129(5):1984-1999
THZ1 suppresses human non-small-cell lung cancer cells in vitro through interference with cancer metabolism.
Cheng ZJ, Miao DL, Su QY, Tang XL, Wang XL, Deng LB, Shi HD, Xin HB
Acta pharmacologica Sinica 2019 Jun;40(6):814-822
Acta pharmacologica Sinica 2019 Jun;40(6):814-822
The mRNA Export Receptor NXF1 Coordinates Transcriptional Dynamics, Alternative Polyadenylation, and mRNA Export.
Chen S, Wang R, Zheng D, Zhang H, Chang X, Wang K, Li W, Fan J, Tian B, Cheng H
Molecular cell 2019 Apr 4;74(1):118-131.e7
Molecular cell 2019 Apr 4;74(1):118-131.e7
Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Huang J, Weng T, Ko J, Chen NY, Xiang Y, Volcik K, Han L, Blackburn MR, Lu X
Biochemical and biophysical research communications 2018 Sep 5;503(2):856-862
Biochemical and biophysical research communications 2018 Sep 5;503(2):856-862
Effect of CFIm25 knockout on RNA polymerase II transcription.
Tellier M, Hardy JG, Norbury CJ, Murphy S
BMC research notes 2018 Dec 14;11(1):894
BMC research notes 2018 Dec 14;11(1):894
CFIm25 regulates glutaminase alternative terminal exon definition to modulate miR-23 function.
Masamha CP, Xia Z, Peart N, Collum S, Li W, Wagner EJ, Shyu AB
RNA (New York, N.Y.) 2016 Jun;22(6):830-8
RNA (New York, N.Y.) 2016 Jun;22(6):830-8
Coupling between alternative polyadenylation and alternative splicing is limited to terminal introns.
Movassat M, Crabb TL, Busch A, Yao C, Reynolds DJ, Shi Y, Hertel KJ
RNA biology 2016 Jul 2;13(7):646-55
RNA biology 2016 Jul 2;13(7):646-55
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors.
Misra A, Ou J, Zhu LJ, Green MR
Molecular cell 2015 Jun 4;58(5):819-31
Molecular cell 2015 Jun 4;58(5):819-31
The Mediator subunit MED23 couples H2B mono-ubiquitination to transcriptional control and cell fate determination.
Yao X, Tang Z, Fu X, Yin J, Liang Y, Li C, Li H, Tian Q, Roeder RG, Wang G
The EMBO journal 2015 Dec 2;34(23):2885-902
The EMBO journal 2015 Dec 2;34(23):2885-902
CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.
Masamha CP, Xia Z, Yang J, Albrecht TR, Li M, Shyu AB, Li W, Wagner EJ
Nature 2014 Jun 19;510(7505):412-6
Nature 2014 Jun 19;510(7505):412-6
Evidence that cleavage factor Im is a heterotetrameric protein complex controlling alternative polyadenylation.
Kim S, Yamamoto J, Chen Y, Aida M, Wada T, Handa H, Yamaguchi Y
Genes to cells : devoted to molecular & cellular mechanisms 2010 Sep 1;15(9):1003-13
Genes to cells : devoted to molecular & cellular mechanisms 2010 Sep 1;15(9):1003-13
Pre-messenger RNA cleavage factor I (CFIm): potential role in alternative polyadenylation during spermatogenesis.
Sartini BL, Wang H, Wang W, Millette CF, Kilpatrick DL
Biology of reproduction 2008 Mar;78(3):472-82
Biology of reproduction 2008 Mar;78(3):472-82
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- human brain tissue were subjected to SDS PAGE followed by western blot with 10322-1-AP(NUDT21 antibody) at dilution of 1:500
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunofluorescent analysis of MCF-7 cells, using NUDT21 antibody 10322-1-AP at 1:50 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunohistochemical of paraffin-embedded human placenta using 10322-1-AP(NUDT21 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunohistochemical of paraffin-embedded human placenta using 10322-1-AP(NUDT21 antibody) at dilution of 1:50 (under 40x lens)
- Sample type
- tissue